Akebia Therapeutics Inc (AKBA)

Deferred Revenue

$6.17M

Quarterly · Period ending: · USD

AKBA logo

AKBA Deferred Revenue

Latest reported$6.17M
AKBA Quarterly Deferred Revenue ($0.00 → $6.17M)
High-resolution chart · PNG

AKBA deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Akebia Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
6,169,000
4,496,000
2,681,000
3,881,000
5,532,000
1,241,000
0
0
0
695,000
0
0
23,303,000
0
3,738,000
1,265,000
5,047,000
10,440,000
20,906,000
15,692,000
11,869,000
18,253,000
53,263,000
18,034,000
23,529,000
66,726,000
70,382,000
32,142,000
40,316,000
49,584,000
56,980,000
70,099,000
78,613,000
78,592,000
84,910,000
121,031,000
142,346,000
84,108,000
81,968,000
40,000,000
40,000,000
40,000,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.